💡 Johnson & Johnson: $14.6 billion acquisition strengthens the pharmaceutical giant's position in the neurological drugs market 💊
Johnson & Johnson $JNJ, one of the biggest players in the healthcare industry, has once again shown that growth through strategic acquisitions is their forte.
The company announced last week the purchase of biopharmaceutical firm Intra-Cellular...
Read more
I don't follow this company anymore and I don't care. The stock has barely risen at all in the long term and the dividend isn't very high either. I find $NVO much more interesting.